China National Medicines (SHSE:600511) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Change In Receivables?

China National Medicines's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means China National Medicines's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

China National Medicines's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-293 Mil. It means China National Medicines's Accounts Receivable increased by ¥293 Mil from Dec. 2022 to Dec. 2023 .

China National Medicines's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥9,630 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. China National Medicines's Days Sales Outstanding for the three months ended in Mar. 2024 was 72.49.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. China National Medicines's liquidation value for the three months ended in Mar. 2024 was ¥3,772 Mil.

China National Medicines Change In Receivables Historical Data

The historical data trend for China National Medicines's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Change In Receivables Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-1,632.63

-107.14

-714.22

599.77

-292.55

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

China National Medicines Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

China National Medicines (SHSE:600511) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

China National Medicines's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	9629.511	/	12122.143	*	91
=	72.49

2. In Ben Graham's calculation of liquidation value, China National Medicines's accounts receivable are only considered to be worth 75% of book value:

China National Medicines's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	9294.802	-	14898.013	+	0.75 * 9629.511	+	0.5 * 4306.487
=	3,772

China National Medicines Change In Receivables Related Terms

Thank you for viewing the detailed overview of China National Medicines's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines